Home / news / Takeda Acquires Ariad Pharmaceuticals in $5.2 Billion Deal

Takeda Acquires Ariad Pharmaceuticals in $5.2 Billion Deal

collected by :Rechard Bernard

follow the latest news of” market news” from different sites to most famous technicals / by 2017-01-10 at 8:10

As it stated in

Ariad Pharmaceuticals to be acquired by Takeda for $5.2 billion

Ariad Pharmaceuticals to be acquired by Takeda for $5.2 billion*/

– Takeda’s transaction will give the Japanese drug giant rights to Iclusig, the approved Ariad drug to treat chronic myeloid leukemia.Ariad Pharmaceuticals Inc. on Monday accepted a $5.2 billion takeover offer from Japan’s Takeda Pharmaceuticals Inc., making the Cambridge company the latest Massachusetts biotech to be gobbled up by a global drug company seeking to strengthen its product line.The 26-year-old Ariad has a blood cancer drug on the market and is seeking US approval for a lung cancer treatment.
.

read more from here

Ariad Pharmaceuticals (Nasdaq: ARIA) Agrees to $5.2 Billion Buy-out – Stock News Union

Ariad Pharmaceuticals (Nasdaq: ARIA) Agrees to $5.2 Billion Buy-out – Stock News Union*/

– Ariad Pharmaceuticals, Inc. – Nasdaq: ARIATakeda Pharmaceutical Company Inc. has agreed to purchase Cambridge, MA-based Ariad Pharmaceuticals for $24 per share.Ariad’s shares, traded on the Nasdaq under ticker ARIA, closed Friday at $13.74 and shot up to an intraday high of $23.81.The $5.2 Billion deal represents a 75% premium over the Friday closing price.
.

read more from here

Takeda Acquires Ariad Pharmaceuticals in $5.2 Billion Deal

Takeda Acquires Ariad Pharmaceuticals in $5.2 Billion Deal*/


.

read more from here

read more
visit us
news

Check Also

cheap stocks

Cheap stocks and its trading in financial markets

Cheap stocks, also known as Cent stocks, are ordinary shares of small public companies traded …